Financhill
Back

BioVie, Inc. 10K Form

Sell
42

BIVI
BioVie, Inc.

Last Price:
$1.58
Seasonality Move:
9.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BIVI News And Ratings

See the #1 stock for the next 7 days that we like better than BIVI

BIVI Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-3M
Price / Cash Flow: 0
Annual Sales: $3.31
Price / Book: 0.12

Profitability

EPS (TTM): -7.51100
Net Income (TTM): $-18.5M
Gross Margin: $-229.4K
Return on Equity: -89.06%
Return on Assets: -77.01%

BioVie, Inc. Earnings Forecast

Key BioVie, Inc. Financial Ratios

  • Per Share Earnings over the last 14 years have been positive in 4 years.

BioVie, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIVI
Website: bioviepharma.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 15.83
Quick Ratio: 15.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIVI Technical Analysis vs Fundamental Analysis

Sell
42
BioVie, Inc. (BIVI) is a Sell

Is BioVie, Inc. a Buy or a Sell?

  • BioVie, Inc. stock is rated a Sell
    The current BioVie, Inc. [BIVI] share price is $1.61. The Score for BIVI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.